04:48 PM EST, 11/07/2024 (MT Newswires) -- Profound Medical ( PROF ) was at last look down 1.8% in US after hours Thursday after it reported third quarter net loss widened but revenue jumped 64%.

The medical-device company's loss widened to US$9.4 million, or US$0.38 per share, from US$5.6 million, or US$0.26, last year.

Revenue jumped 64% to US$2.83 million, of which US$2.65 million was recurring revenue.

Profound reaffirmed its revenue guidance for fiscal 2024 to be between US$11 million to US$12 million, for total growth of 53% to 67%.

Profound Medical ( PROF ) shares were last seen down US$0.16 to US$8.80 in after-hours New York trade. They closed $1.15 higher, to $12.35, on the Toronto Stock Exchange.